The Orphan Drug Act, is the FDA Bringing the 1983 Act Up to 21st Century Standards?

Over three decades ago, the United States Congress passed the Orphan Drug Act (ODA) in 1983. The act focused on encouraging drug development for rare diseases, which the agency defined as “affecting fewer than 200,000 people.” When new FDA commissioner, Scott Gottlieb, M.D., joined the FDA in 2016 he promised to revamp the ODA and … Continue reading The Orphan Drug Act, is the FDA Bringing the 1983 Act Up to 21st Century Standards?